Gene | Sequence (5´-3´) | Amplicon (pb) | Application | |
---|---|---|---|---|
SOST | Forward | ATGCCACGGAAATCATCCCC | 185 | Expression in vascular tissue. Check the efficiency of cells transduction. Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | GTCACGTAGCGGGTGAAGTG | |||
RPL13 | Forward | CGTAAGATCCGCAGACGTAAGGC | 228 | Constitutive gene |
Reverse | GGACTTGTTCCGCCTCCTCGGAT | |||
ALPL | Forward | GGCTGGAGATGGACAAGTTC | 152 | Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | ACGCTCAGTGGCTGCGCTTA | |||
RUNX2 | Forward | CGCCGTGGTCCTATGACCAGTCTTA | 169 | Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | AGGCAGAAGTCAGAGGTGGCAGTGT | |||
IL1β | Forward | CTTCAGGCAGGCCGCGTCAGTTGTT | 202 | Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | CCGGAGCGTGCAGTTCAGTGATCGT | |||
IL6 | Forward | AGACAGCCACTCACCTCTTCAGAAC | 208 | Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | CCAGGCAAGTCTCCTCATTGAATCC | |||
IL8 | Forward | GAGAGTGATTGAGAGTGGACCAC | 112 | Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | CACAACCCTCTGCACCCAGTTT | |||
COX2 | Forward | CCGCCATCATCCTAGTCCTCATCGC | 143 | Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | TAGTCCGCCGTAGTCGGTGTACTCG | |||
ACTA2 | Forward | CATCGTGCTGGACTCTGGAGATGGT | 151 | Quantify the expression under different conditions in VSMCs in vitro. |
Reverse | GAAGGAATAGCCACGCTCAGTCAGG |